Clinical Trial Update: Urine Sample Collection From FOP Patients

View source ↗

Summary

A completed clinical trial update noting urine sample collection from Fibrodysplasia Ossificans Progressiva patients (NCT02066324).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Fibrodysplasia Ossificans Progressiva | Status: COMPLETED